Blood test IDs key Alzheimer’s marker

A study led by researchers at Washington University School of Medicine in St. Louis suggests that measures of amyloid beta in the blood have the potential to help identify people with altered levels of amyloid beta in their brains or cerebrospinal fluid. Ideally, a blood-based screening test would identify people who have started down the path toward Alzheimer’s years before they could be diagnosed based on symptoms. Read more about this research here: https://medicine.wustl.edu/news/blood-test-ids-key-alzheimers-marker-brain/.